vimarsana.com

Page 83 - Dexcom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Impax Asset Management Group plc Has $42 59 Million Position in DexCom, Inc (NASDAQ:DXCM)

Impax Asset Management Group plc reduced its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 5.5% during the second quarter, HoldingsChannel reports. The firm owned 331,445 shares of the medical device company’s stock after selling 19,420 shares during the quarter. Impax Asset Management Group plc’s holdings in DexCom were worth $42,594,000 at the end […]

12 Best Internet of Things (IoT) Stocks To Buy

In this piece, we will take a look at 12 of the best Internet of Things (IoT) stocks to buy. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks To Buy. In the last several decades, technology has undergone significant evolution. It’s not just computers and smartphones that are now […]

Hba1c Testing Device Market Size & Share to Surpass $3 03 Billion by 2030 | Vantage Market Research

WASHINGTON, Oct. 30, 2023 (GLOBE NEWSWIRE) As per Vantage Market Research, the Global Hba1c Testing Device Market has been significantly growing over the years due to the increasing prevalence of diabetes, raising

Dexcom (DXCM) Faces Challenges Over GLP-1s Long-Term Effects on Its Target Market

The Ithaka Group, an investment advisory firm, released the “Ithaka US Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. In the weak market, the fund underperformed during the quarter, by falling 6.3% compared to the Dow’s 2.6% fall, the S&P 500’s 3.7% decline, the NASDAQ’s 4.1% decline, and the […]

11 Undervalued Mid Cap Stocks To Buy According to Analysts

In this piece, we will take a look at the 11 undervalued mid cap stocks to buy. If you want to skip our analysis of mid cap investing and the stock market, then check out 5 Undervalued Mid Cap Stocks To Buy. When it comes to selecting stocks, different sectors allow investors to cater to […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.